0001209191-15-006536.txt : 20150126
0001209191-15-006536.hdr.sgml : 20150126
20150126165742
ACCESSION NUMBER: 0001209191-15-006536
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150123
FILED AS OF DATE: 20150126
DATE AS OF CHANGE: 20150126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly James M
CENTRAL INDEX KEY: 0001560782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 15549161
MAIL ADDRESS:
STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION
STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-23
0
0000879169
INCYTE CORP
INCY
0001560782
Daly James M
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2015-01-23
4
M
0
7731
16.62
A
11252
D
Common Stock
2015-01-23
4
M
0
601
16.62
A
11853
D
Common Stock
2015-01-23
4
M
0
2777
18.32
A
14630
D
Common Stock
2015-01-23
4
S
0
11109
77.68
D
3521
D
Non-Qualified Stock Option (right to buy)
16.62
2015-01-23
4
M
0
7731
0.00
D
2019-10-21
Common Stock
7731
69587
D
Non-Qualified Stock Option (right to buy)
16.62
2015-01-23
4
M
0
601
0.00
D
2019-10-21
Common Stock
601
5415
D
Non-Qualified Stock Option (right to buy)
18.32
2015-01-23
4
M
0
2777
0.00
D
2020-02-08
Common Stock
2777
30655
D
Represents weighted average sale price. Actual sale prices ranged from $76.99 - $78.10.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ James M. Daly
2015-01-26